Bimekizumab Efficacy and Safety in Patients With Psoriatic Arthritis Who Had Skin and Nail Psoriasis at Baseline: Up to 2-year Results From Two Phase 3 Studies. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), s435. https://doi.org/10.25251/skin.8.supp.435